| related words |
| decodeme |
| sanctura |
| abthrax |
| carcinogenicity |
| levoleucovorin |
| advexin |
| analyzer |
| medimmune |
| finishing |
| ipilimumab |
| synthesis |
| bioequivalence |
| neuropathic |
| apap |
| preapproval |
| biosensors |
| pediatric |
| subgroup |
| outlicensing |
| enzyme |
|
| related documents |
| 872589--2/26/2009--REGENERON_PHARMACEUTICALS_INC |
|
| related topics |
| {product, candidate, development} |
| {stock, price, share} |
| {product, liability, claim} |
| {property, intellectual, protect} |
| {stock, price, operating} |
| {control, financial, internal} |
| {provision, law, control} |
| {cost, operation, labor} |
| {regulation, government, change} |
| {loan, real, estate} |
| {cost, regulation, environmental} |
| {personnel, key, retain} |
| {operation, natural, condition} |
| {capital, credit, financial} |
| {regulation, change, law} |
| {gas, price, oil} |
| {competitive, industry, competition} |
| {acquisition, growth, future} |
| {product, market, service} |
| {operation, international, foreign} |
|